These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7807690)

  • 21. [Pharmacokinetic and clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
    Jpn J Antibiot; 1989 Jul; 42(7):1629-66. PubMed ID: 2681864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sugita M; Takahashi T; Fukushima Y; Yamasaki M; Hori M
    Jpn J Antibiot; 1989 Jul; 42(7):1519-46. PubMed ID: 2810728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Appraisal of rokitamycin in the pediatric field].
    Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatasuma Y; Fukushima N
    Jpn J Antibiot; 1988 Jun; 41(6):646-62. PubMed ID: 3221430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study on clarithromycin granule and tablet in the field of pediatrics].
    Motohiro T; Sakata Y; Kuroiwa Y; Aramaki M; Oda K; Kawakami A; Shimada Y; Tanaka K; Koga T; Fujimoto T
    Jpn J Antibiot; 1989 Feb; 42(2):423-64. PubMed ID: 2526256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optimum dose study of cefozopran in the pediatric field].
    Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
    Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
    Haruta T; Kuroki S; Hashimoto N; Suzuki N; Okura K; Kobayashi Y
    Jpn J Antibiot; 1989 Jul; 42(7):1621-8. PubMed ID: 2562790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic and clinical studies on clarithromycin in pediatrics].
    Iwai N; Taneda Y; Miyazu M; Nakamura H; Kasai K
    Jpn J Antibiot; 1989 Feb; 42(2):304-22. PubMed ID: 2526244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1989 Jul; 42(7):1547-60. PubMed ID: 2810729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacteriological, pharmacokinetic and clinical evaluation of azithromycin in the pediatric field].
    Akita H; Sato Y; Kusumoto Y; Iwata S; Takeuchi Y; Aoyama T; Yokota T; Sunakawa K
    Jpn J Antibiot; 1996 Oct; 49(10):899-916. PubMed ID: 8986553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and clinical effects of cefozopran in pediatric patients.
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H
    Jpn J Antibiot; 1996 Jan; 49(1):17-33. PubMed ID: 8851304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetic and clinical studies of S-1108 in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Sano T; Nakamura H
    Jpn J Antibiot; 1993 Nov; 46(11):991-1002. PubMed ID: 8309075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of cefpodoxime proxetil dry syrup for skin and soft tissue infections in the field of pediatrics].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
    Jpn J Antibiot; 1989 Jul; 42(7):1685-704. PubMed ID: 2681866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].
    Fujii R; Meguro H; Arimasu O; Ushijima K; Abe T; Nakazawa S; Sato H; Narita A; Niino K; Ichihashi H
    Jpn J Antibiot; 1990 Jan; 43(1):181-215. PubMed ID: 2190014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
    Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of clarithromycin in treatment of acute dental infections. Comparative double-blind study using josamycin as the control].
    Sasaki J; Morishima T; Sakamoto H; Takai H; Ikeshima K; Shiiki K; Uematsu M; Morihana T; Tomita F; Noma H
    Jpn J Antibiot; 1989 Apr; 42(4):983-1013. PubMed ID: 2528004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Laboratory and clinical studies of clarithromycin in pediatric fields].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1989 Feb; 42(2):353-69. PubMed ID: 2526248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and laboratory studies on SY5555 in pediatric infectious diseases].
    Wakiguchi H; Nagao A; Watanabe S; Okada T; Hamada F; Kurashige T
    Jpn J Antibiot; 1995 Feb; 48(2):229-37. PubMed ID: 7745813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic and clinical studies on norfloxacin in the pediatric field].
    Iwai N; Nakamura H; Miyazu M; Katayama M; Kasai K
    Jpn J Antibiot; 1990 Sep; 43(9):1629-48. PubMed ID: 2262968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on S-1108 in pediatric infection].
    Niinou K; Sato H
    Jpn J Antibiot; 1993 Nov; 46(11):978-90. PubMed ID: 8309074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic studies on oral antibiotics in pediatrics. I. A pharmacokinetic study on cefixime in pediatrics].
    Nakamura H; Iwai N
    Jpn J Antibiot; 1991 Sep; 44(9):964-78. PubMed ID: 1960858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.